Exploration of vulnerability in neurodegenerative diseases: Determination skills of genetic and environmental risk factors

Welch Bonnie; E Heck Diane; Duck Kim Hong

doi:10.30574/gscbps.2020.12.2.0226

Authors

Welch Bonnie Department of Public Health, School of Health Sciences and Practice, New York Medical College, Valhalla NY.
E Heck Diane Department of Public Health, School of Health Sciences and Practice, New York Medical College, Valhalla NY.
Duck Kim Hong Department of Public Health, School of Health Sciences and Practice, New York Medical College, Valhalla NY.

DOI:

https://doi.org/10.30574/gscbps.2020.12.2.0226

Keywords:

CNS diseases, Alzheimer’s disease (AD), Parkinson’s disease (PD), Amyotrophic lateral sclerosis (ALS), metabolomics, molecular based risk assessment skills, Omics

Abstract

Neurodegenerative diseases (ND) affect a large portion of our elder population with cognitive impairment, impaired movement due to loss of balance or muscle weakness in motor neuron. Due to their irreversible nature they present a significant public health burden through the demand on our health care system as well as by unmet therapeutic measures that influence socioeconomic decision processes, while our current population is transitioned to an aged community. Here we introduce top 3 of the most prevalent NDs and examine preventive alternatives along with the available research on both genetic and environmental risk factors. While many questions remain, genetic predisposition combined with environmental exposures may be to blame for a large number of these cases. Utilizing emerging multi-fold omics technologies, early prevention aided by development of biomarker can help to identify risk factors and to envision new avenue in new treatments option in the future.

Metrics

Metrics Loading ...

References

EU Joint Programme-Neurodegenerative Disease (JPND). (2019). What is Neurodegenerative Disease?

Alzheimer’s Association (AA). (2020). Facts and Figures.

National Institutes of Health (NIH). (2015). Alzheimer's disease Genetics Fact Sheet.

Wilkins JM and Trushina E. (2018). Application of metabolomics in Alzheimer’s disease. Frontiers in neurology, 8, 719.

Chin-Chan M, Navarro-Yepes J and Quintanilla-Vega B. (2015). Environmental pollutants as risk factors for neurodegenerative disorders: Alzheimer and Parkinson diseases. Frontiers in cellular neuroscience, 9, 124.

Dimakakou E, Johnston HJ, Streftaris G and Cherrie JW. (2018). Exposure to environmental and occupational particulate air pollution as a potential contributor to neurodegeneration and diabetes: a systematic review of epidemiological research. International journal of environmental research and public health, 15(8), 1704.

Bisht K, Sharma K and Tremblay MÈ. (2018). Chronic stress as a risk factor for Alzheimer's disease: Roles of microglia-mediated synaptic remodeling, inflammation, and oxidative stress. Neurobiology of stress, 9, 9-21.

National Institute of Health (NIH). (2017, May 16). Parkinson’s disease.

Georgiou A, Demetriou CA, Christou YP, Heraclides A, Leonidou E, Loukaides P, Yiasoumi E, Pantziaris M, Kleopa K, Papacostas SS, Loizidou M, Andreas Hadjisavvas A, Loizidou MA, Hadjisavvas A and Zamba-Papanicolaou E. (2019). Genetic and environmental factors contributing to Parkinson’s disease: a case-control study in the Cypriot population. Frontiers in neurology, 10, 1047.

Parkinson’s Foundation. (2019, June 13). Statistics.

Pinares-Garcia P, Stratikopoulos M, Zagato A, Loke H and Lee J. (2018). Sex: a significant risk factor for neurodevelopmental and neurodegenerative disorders. Brain sciences, 8(8), 154.

Boulos C, Yaghi N, El Hayeck R, Heraoui GN and Fakhoury-Sayegh N. (2019). Nutritional risk factors, microbiota and Parkinson’s disease: what is the current evidence? Nutrients, 11(8), 1896.

Johns Hopkins Medicine (JHM). (2019, June 11). ALS, Amyotrophic Lateral Sclerosis, Lou Gehrig’s disease.

Bozzoni V, Pansarasa O, Diamanti L, Nosari G, Cereda C and Ceroni M. (2016). Amyotrophic lateral sclerosis and environmental factors. Functional neurology, 31(1), 7.

Shamim SA, Warriach ZI, Tariq MA, Rana KF and Malik BH. (2019). Insomnia: risk factor for neurodegenerative diseases. Cureus, 11(10).

Anttila V, Bulik-Sullivan B, Finucane HK, Walters RK, Bras J Duncan L and Patsopoulos NA. (2018). Analysis of shared heritability in common disorders of the brain. Science, 360(6395).

Bennett DA, Buchman AS, Boyle PA, Barnes LL, Wilson RS and Schneider JA. (2018). Religious orders study and rush memory and aging project. Journal of Alzheimer's disease, 64(s1), S161-S189.

Sheinerman KS, Toledo JB, Tsivinsky VG, Irwin D, Grossman M, Weintraub D and Elman LB. (2017). Circulating brain-enriched microRNAs as novel biomarkers for detection and differentiation of neurodegenerative diseases. Alzheimer's research & therapy, 9(1), 89.

Diaz-Ortiz ME and Chen-Plotkin AS. (2020). Omics in neurodegenerative disease: Hope or hype? Trends in Genetics, 36(3), 152-159.